Severe Acute Respiratory News and Research

RSS
A genome-based comparison of SARS-CoV-2 XBB recombinant and its parental lineage

A genome-based comparison of SARS-CoV-2 XBB recombinant and its parental lineage

SHEA advises against COVID screening of asymptomatic patients

SHEA advises against COVID screening of asymptomatic patients

Scientists find key reason for ongoing loss of smell in long-COVID

Scientists find key reason for ongoing loss of smell in long-COVID

An estimated 19 million US adults living with long-COVID

An estimated 19 million US adults living with long-COVID

Scientists study OAS–RNase L errors and COVID-19-associated multisystem inflammatory syndrome in children

Scientists study OAS–RNase L errors and COVID-19-associated multisystem inflammatory syndrome in children

Exploring plasma and nasal antibody responses to SARS-CoV-2 infection and vaccination

Exploring plasma and nasal antibody responses to SARS-CoV-2 infection and vaccination

Hybrid immunity from mRNA vaccines and breakthrough Omicron infections induces stronger immune responses against Omicron BQ.1.1

Hybrid immunity from mRNA vaccines and breakthrough Omicron infections induces stronger immune responses against Omicron BQ.1.1

High efficacy of SARS-CoV-2 vaccines in preventing COVID-19 deaths in children and adolescents

High efficacy of SARS-CoV-2 vaccines in preventing COVID-19 deaths in children and adolescents

Beta-containing COVID-19 booster vaccine found to cross-neutralize variants in non-human primates

Beta-containing COVID-19 booster vaccine found to cross-neutralize variants in non-human primates

COVID-19 vaccination protects people with B cell lymphoma and multiple myeloma

COVID-19 vaccination protects people with B cell lymphoma and multiple myeloma

Bivalent mRNA vaccine is moderately effective in preventing COVID-19

Bivalent mRNA vaccine is moderately effective in preventing COVID-19

T-cell immunity remains effective against SARS-CoV-2 Omicron subvariants

T-cell immunity remains effective against SARS-CoV-2 Omicron subvariants

Dutch study shows the effectiveness of COVID vaccination in reducing hospitalizations

Dutch study shows the effectiveness of COVID vaccination in reducing hospitalizations

History of COVID-19 increases risk of fatigue and other long COVID symptoms in adults and children

History of COVID-19 increases risk of fatigue and other long COVID symptoms in adults and children

WHO releases a global strategy for infection prevention and control at the 75th World Health Assembly

WHO releases a global strategy for infection prevention and control at the 75th World Health Assembly

SARS-CoV-2 and human cold coronavirus OC43 inhibit stress granule formation through Nsp15 protein

SARS-CoV-2 and human cold coronavirus OC43 inhibit stress granule formation through Nsp15 protein

What are the long-term outcomes of critical COVID-19 patients?

What are the long-term outcomes of critical COVID-19 patients?

Review on nanoparticles usage for treating thrombosis induced by SARS-CoV-2 infections

Review on nanoparticles usage for treating thrombosis induced by SARS-CoV-2 infections

Age-stratified analysis of COVID-19 severity outcomes among vaccinees and individuals with prior SARS-CoV-2 exposure in Indiana

Age-stratified analysis of COVID-19 severity outcomes among vaccinees and individuals with prior SARS-CoV-2 exposure in Indiana

Exploring environmental viral emissions after SARS-CoV-2 Human challenge

Exploring environmental viral emissions after SARS-CoV-2 Human challenge

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.